Heart failure project likely to be recognised as enhanced service
BSIP, Mendil/Science Photo Library
 Patient progress is monitored monthly |
An award winning community pharmacy heart failure medicines service in Scotland is on track to receive funding to continue as a locally enhanced service.
The Glasgow community pharmacy heart failure team won the National
Pharmacy Association, Guild of Healthcare Pharmacists, NHS Alliance,
Merck Sharp & Dohme
joint pharmacy award for 2005–06 (PJ, 19 November 2005, p625),
which allowed them to evaluate pharmacists’ and patients’ views
of the adherence support service.
“As a result of the case made by evaluation of the service (including
the qualitative research) it is on the cards that the service will receive
ongoing funding as a locally enhanced service,” said Richard Lowrie,
lead clinical pharmacist at NHS Greater Glasgow and team leader. Mr Lowrie
presented some of the results of the evaluation at the NHS Alliance annual
conference held in Bournemouth last week.
He explained that patients are referred to a community pharmacy of their
choice (90 per cent of pharmacies in Glasgow offer the service) by prescribing
support pharmacists, hospital pharmacists or heart failure liaison nurses.
Community pharmacists follow up any specified issues, carry out an initial
assessment of symptoms and monitor progress against this baseline every
month (PJ, 5 March 2005, p258).
In telephone interviews with 65 patients who had used the service, 67
per cent said their knowledge of heart failure had improved, 72 per cent
said their knowledge of their medicines had improved, 59 per cent said
that their knowledge of their symptoms had improved and 9 per cent said
their routine for taking their heart failure medicines had changed. “We
were not too disappointed with that last result since we did not select
patients on the basis that they were poor compliers,” said Mr Lowrie.
Part of the evaluation has come as a result of joint work between NHS
Glasgow Community Pharmacy Development Team and the University of Strathclyde
department of pharmaceutical sciences.
The award for 2006–07 is currently under review with a view to
broadening it to include primary care pharmacists and other health care
professionals who work alongside pharmacists. Further information will
be announced next year. |